If you see any issues with the assignment handout or code, please feel free to raise a GitHub issue or open a pull request with a fix. Download the TinyStories data ...

FWC announces winners of the 2025 Florida Python Challenge TAMPA, Fla. (WFLA )— In just about a week, registered participants ...

Florida Python Challenge To combat the Burmese python, one of the region's most destructive invasive species, Florida is once ...

A 1985 pop song so captivating that its opening seconds are instantly recognizable and evoke strong emotions cemented its place in music history 41 years ago today. Tears for Fears' "Everybody Wants ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

Earlier this spring, it seemed all of higher education was talking about Einstein, a tool specifically marketed to students for its ability to autonomously log on to the learning management system ...

Ready to hand over the car keys to a teenager for the first time? The Insurance Institute for Highway Safety and Consumer Reports are out with a list of cars to help get them safely from point A to ...

That one teacher who be giving us homework like we don't have other classes 😭📚 They really act like their subject is the only thing on our schedule 💀 One minute it’s “just a small assignment” and ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

GLP-1 insurance coverage for weight loss varies greatly by plan type. Private insurance often excludes these drugs entirely, while Medicare is opening pathways for coverage. Still, access depends on ...

If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a commercial. Like millions of others around the country, if you’ve ever ...

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...